Detalhe da pesquisa
1.
A Proposal for Standardization of Early Outcomes Following Robot-Assisted Radical Cystectomy (RARC): RARC Tetrafecta.
Ann Surg Oncol
; 31(7): 4752-4761, 2024 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-38538821
2.
Rate of benign histology after resection of suspected renal cell carcinoma: multicenter comparison between Korea and the United States.
BMC Cancer
; 24(1): 216, 2024 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38360715
3.
Retrospective Multicenter Analysis of Prognostic Risk Factors for One Year Recurrence in Patient With Renal Cell Carcinoma After Partial or Radical Nephrectomy: Results of Korean Renal Cancer Study Group (KRoCS) Database.
J Korean Med Sci
; 39(3): e11, 2024 Jan 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38258358
4.
Sextant Systematic Biopsy Versus Extended 12-Core Systematic Biopsy in Combined Biopsy for Prostate Cancer.
J Korean Med Sci
; 39(7): e63, 2024 Feb 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-38412610
5.
Fat Loss in Patients with Metastatic Clear Cell Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors.
Int J Mol Sci
; 24(4)2023 Feb 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-36835404
6.
Cabozantinib-Loaded PLGA Nanoparticles: A Potential Adjuvant Strategy for Surgically Resected High-Risk Non-Metastatic Renal Cell Carcinoma.
Int J Mol Sci
; 23(20)2022 Oct 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-36293494
7.
Renal Cell Carcinoma-Infiltrating CD3low Vγ9Vδ1 T Cells Represent Potentially Novel Anti-Tumor Immune Players.
Curr Issues Mol Biol
; 43(1): 226-239, 2021 May 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-34071865
8.
A prospective phase-II trial of biweekly docetaxel plus androgen deprivation therapy in patients with previously-untreated metastatic castration-naïve prostate cancer.
BMC Cancer
; 21(1): 1281, 2021 Nov 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-34839812
9.
Targeted therapy response in early versus late recurrence of renal cell carcinoma after surgical treatment: A propensity score-matched study using the Korean Renal Cancer Study Group database.
Int J Urol
; 28(4): 417-423, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33527588
10.
Functions of human liver CD69+CD103-CD8+ T cells depend on HIF-2α activity in healthy and pathologic livers.
J Hepatol
; 72(6): 1170-1181, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31987989
11.
Strategy for Prostate Cancer Patients with Low Prostate Specific Antigen Level (2.5 to 4.0 ng/mL).
J Korean Med Sci
; 35(41): e342, 2020 Oct 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-33107227
12.
A randomized, double-blind, placebo-controlled trial to evaluate the role of curcumin in prostate cancer patients with intermittent androgen deprivation.
Prostate
; 79(6): 614-621, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30671976
13.
Is Primary Androgen Deprivation Therapy a Suitable Option for Asian Patients With Prostate Cancer Compared With Radical Prostatectomy?
J Natl Compr Canc Netw
; 17(5): 441-449, 2019 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31085754
14.
Combination of multiparametric magnetic resonance imaging and transrectal ultrasound-guided prostate biopsies is not enough for identifying patients eligible for hemiablative focal therapy for prostate cancer.
World J Urol
; 37(10): 2129-2135, 2019 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-30603783
15.
A retrospective feasibility study of biweekly docetaxel in patients with high-risk metastatic castration-naïve prostate cancer.
BMC Urol
; 19(1): 30, 2019 May 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31053137
16.
Cancer Location in Upgrading and Detection after Transperineal Template-Guided Mapping Biopsy for Patients in Active Surveillance and Negative Transrectal Ultrasonography-Guided Prostate Biopsy.
Urol Int
; 103(3): 262-269, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31269509
17.
Changeable Conditional Survival Rates and Associated Prognosticators in Patients with Metastatic Renal Cell Carcinoma Receiving First Line Targeted Therapy.
J Urol
; 200(5): 989-995, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-29940249
18.
RFA versus robotic partial nephrectomy for T1a renal cell carcinoma: a propensity score-matched comparison of mid-term outcome.
Eur Radiol
; 28(7): 2979-2985, 2018 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-29426988
19.
Efficacy of First-Line Targeted Therapy in Real-World Korean Patients with Metastatic Renal Cell Carcinoma: Focus on Sunitinib and Pazopanib.
J Korean Med Sci
; 33(51): e325, 2018 Dec 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-30546281
20.
Prognostic impact of the pretreatment aspartate transaminase/alanine transaminase ratio in patients treated with first-line systemic tyrosine kinase inhibitor therapy for metastatic renal cell carcinoma.
Int J Urol
; 25(6): 596-603, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29756394